Primary infections (e.g., respiratory, urinary tract, or gastrointestinal) often result in bloodstream infection (BSI) and may cause fever. Thus, the management of febrile inpatients may be greatly assisted by the detection of BSI. Since blood is a normally sterile site, blood cultures, properly performed, have a high positive predictive value for BSI. The diagnosis of BSI, however, is difficult in developing countries, where diagnostic microbiology services may be limited or absent. In regions (e.g., sub-Saharan Africa) with a high prevalence of human immunodeficiency virus (HIV) type 1 infection and limited microbiology resources, a number of pathogens that cause BSI may go undetected.
blood only for bacteremia but not for fungemia or mycobacteremia [1, 2] . Workers in 2 more recent studies in Tanzania [3] and Uganda [4] cultured blood comprehensively for bacteria, mycobacteria, and fungi and documented that M. tuberculosis was the predominant cause of BSI in adults admitted to the medical service with fever. Data from such microbiologic studies are critically important to guide development of algorithms for empiric treatment of BSI in these regions.
Given the wide variation in results of these studies, we designed a study to determine prospectively the epidemiology and etiology of BSI in adults who presented with fever to Malawi's Lilongwe Central Hospital (LCH), by use of simple microbiologic techniques to culture blood comprehensively for bacteria, mycobacteria, and fungi and to identify simple clinical predictors for BSI.
Materials and Methods
Setting. LCH is the largest government regional medical center in central Malawi. It has ∼500 beds and provides services to a patient catchment area of 230,000 citizens, regardless of their ability to pay. During the dry season, there are ∼4-8 admissions to the medical service per day, and ∼50% of these patients have febrile illnesses. Fevers in adult patients are most often attributed to malaria, tuberculosis, diarrhea, sepsis, or HIV-1 infection. LCH clinicians estimate that 30%-40% of febrile adult patients receive antimicrobials or antimalarials before hospital admission. At LCH, sanatorium affiliated with LCH for appropriate treatment and follow-up.
The microbiology facilities at LCH are limited to Gram's stains, which are routinely made on specimens submitted to the hospital laboratory, and the preparation and examination of blood smears for malaria. Thus, many of the clinical diagnoses are never confirmed. Cultures of cerebrospinal fluid and occasional blood cultures for selected patients are done at the Community Health Sciences Unit, located ∼1.6 km from the hospital.
Patients. For each 24-h period from 20 August through 16 September 1997 (study period and height of the dry season in Malawi), all febrile (axillary temperature у37.5ЊC) adults (aged у18 years) presenting to the medical service at LCH, regardless of symptoms, were seen in the outpatient department by clinical officers supervised by one of the study's principal investigators. A history was obtained from each study patient, followed by a physical examination. Data were recorded on standardized clinical assessment forms and included age, sex, history and duration of acute and chronic symptoms, receipt of antimicrobial therapy before hospital admission, clinical findings, whether patients were admitted to the wards or managed as outpatients, and whether patients admitted to hospital for therapy survived. Fever and diarrhea were deemed chronic if present 11 month; cachexia was defined as weight loss у10% of usual body weight.
After the patient's skin was cleaned with 2% tincture of iodine and 70% alcohol, 30 mL of venous blood was drawn for culture, blood count, and HIV-1 serology. All patients received HIV-1 pretest counseling. HIV-1 test results were reported to the physician in charge of the patient's inpatient care and posttest counseling was provided to patients with a positive HIV-1 test. The ward was notified as soon as an organism was isolated from the blood and again when the organism was identified. Physicians and other ward staff were given advice on antimicrobial regimens, where appropriate. Additional diagnostic tests, such as chest radiographs, sputum smears for acid-fast bacilli (AFB), and blood counts, were requested when deemed appropriate by clinicians.
Blood cultures. In total, 25 mL of blood was cultured: 5 mL was inoculated into a Myco-F-Lytic (MFL) blood culture bottle designed for use in BACTEC 9000 series automated blood culture instruments (Becton Dickinson Microbiology Systems [BDMS], Cockeysville, MD), another 10 mL was added to an isolator tube (Isolator 10; Wampole Laboratories, Cranbury, NJ), and, last, 10 mL was inoculated into a Septi-Chek (SC; BDMS) biphasic blood culture bottle.
The isolator tube was processed as recommended by the manufacturer, and portions of the lysis centrifugation concentrate were cultured for mycobacteria in an SC-AFB biphasic blood culture bottle (BDMS) and for fungi on inhibitory mold agar (IMA) slants as described elsewhere [5] . All blood culture bottles and agar slants were incubated aerobically at 35ЊC.
MFL blood culture bottles were examined for growth with a UV lamp to detect fluorescence of the indicator at the bottom of the bottle. This was done daily during the first week and then once a week for 8 weeks. SC-AFB bottles were examined once a week for 8 weeks or until growth was observed. IMA slants were read macroscopically daily during the first week then weekly for 4 weeks or until growth was observed. Preliminary identification of bacteria and fungi was made on site by standard microbiologic tests.
All blood culture bottles and all bacteria, fungi, or mycobacteria isolates that were isolated at the study site were transported to the Clinical Microbiology Laboratory at Duke University Medical Center where mycobacteria and fungi cultures were processed, and the identities of bacteria and fungi isolates were confirmed. Mycobacterium species were identified by DNA probes (AccuPROBE; Gen-Probe, San Diego) for M. tuberculosis complex and M. avium complex, biochemical tests, and high-performance liquid chromatography (HPLC).
Malaria smears. Thick smears were prepared from the blood of each patient enrolled in the study. Smears were stained with a modified Wright stain and examined microscopically for the presence of any malaria parasites. Malaria smear results were correlated with results obtained using the Parasight F (BDMS) on a subset of enrolled patients to confirm results from microscopy. In addition, smears were prepared from the blood of a randomly selected control group of adult patients who were attending the outpatient department for minor trauma, who did not have fever, and who were otherwise healthy.
HIV-1 testing. Serum samples were assayed in batches using ELISA test kits (SUDS HIV 1&2; Murex Diagnostics, Norcross, GA). Positive HIV ELISA results were repeated before results were reported to patients or physicians.
Antimicrobial susceptibility testing. Tests were performed at Duke University Medical Center as recommended by the National Committee for Clinical Laboratory Standards [6, 7] . Susceptibilities of gram-negative organisms were tested by Microscan Walkaway (Baxter Diagnostics, Deerfield, IL). Other susceptibilities were determined by disk diffusion. The MIC of penicillin was determined by E-test (AB Biodisk, Culver City, CA) for all S. pneumoniae that appeared resistant on oxacillin disk diffusion screening. The susceptibilities of M. tuberculosis isolates were determined by the BACTEC radiometric method (Becton Dickinson Diagnostics Instrument Systems, Sparks, MD).
Data analysis. Data from clinical assessment forms and results from blood cultures, malaria smears, and HIV-1 serology were entered into a computer and analyzed using Epi Info statistical software (version 6.02; CDC, Atlanta). Groups were compared by x 2 or Fisher's exact test, where appropriate. Continuous variables were compared by Wilcoxon rank sum test. Relative risks (RRs), odds ratios (ORs), and 95% confidence intervals (CIs) were calculated. Multivariate analysis using logistic regression was performed using PC SAS software (SAS Institute, Cary, NC).
Results
Clinical characteristics of study cohort. During the study period, we assessed ∼375 adult patients in the LCH outpatient department; 233 (62%) met the case definition of fever and were admitted to the study. The median age of all patients in the study cohort was 31 years (range, 18-64); 128 patients (55%) were male. The median body temperature was 38.8ЊC (range, 37.5-40.9). In all, 132 patients (57%) were admitted to LCH for further evaluation and therapy, and 101 (43%) were followed and treated in the outpatient clinic. A clinical diagnosis of malaria was made in 114 patients (49%) at the initial eval- patients with 3 independent risk factors (HIV-1 infection, altered mental status, and herpes zoster scar) had positive blood cultures, as did 47% (15/32) of those with 2 of these risk factors, 32% (43/138) of those with 1 risk factor, and 12% (7/58) of patients with none of the 3 risk factors. Moreover, having more than 1 risk factor (HIV-1 infection, altered mental status, and herpes zoster scar) was 90% (63/70) sensitive but 31% (51/163) specific in predicting BSI. Mycobacteremia occurred in 59% (10/17) of patients with 3 independent risk factors (pleural effusion, oral candidiasis, or chronic fever), 17% (10/58) of those with 2 risk factors, 4% (4/110) with 1 risk factor, and in none (0/48) with no risk factors. All patients with mycobacteremia were HIV-1 positive (table  4) . Having more than 1 of these mycobacteremia risk factors was 100% (24/24) sensitive and 25% (52/209) specific in predicting mycobacteremia.
Bacteremia occurred in 33% (5/15) of patients with pulmonary consolidation and 17% (37/218) of those without. Fungemia was found in 11% (3/27) of patients with altered mental status and 1% (2/206) of those without this clinical feature.
Predictors for inpatient mortality. Outcome data (death or discharge from hospital) were available for 131 (99%) of the 132 study patients who were admitted to the medical service for therapy. Of these 131 patients, 27 (21%) died during hospitalization. Patients with HIV-1 infection were as likely to die during hospitalization as patients without HIV-1 infection (24/102 vs. 3/29; RR, 2.3; 95% CI, 0.7-7.0;
). By mul-P = NS tivariate analysis, predictors of inpatient mortality included presence of any BSI (OR, 3.5; 95% CI, 1.4-10.0; ) or P = .01 altered mental status (OR, 6.6; 95% CI, 2.4-18.7;
). P ! .001 Radiographs and sputum smears. Of 21 patients with M. tuberculosis BSI, 15 (71%) were inpatients. Eleven (73%) of the 15 hospitalized patients with M. tuberculosis BSI had no test result (i.e., chest radiograph or sputum smear) or previous therapy to suggest active tuberculosis at the time of admission. Chest radiographs of 5 patients with M. tuberculosis BSI were abnormal; sputum smears prepared for 3 of these 5 patients were negative for AFB.
Antimicrobial susceptibility testing. Of the 25 S. pneumoniae isolates, 8 (32%) had intermediate resistance to penicillin (MIC, 0.1-2.0 mg/mL); all isolates were fully susceptible to thirdgeneration cephalosporins and chloramphenicol. Although the frequency of penicillin resistance among S. pneumoniae isolated from study patients who reported exposure to antibacterial agents before hospital admission was similar to that in patients who reported no exposure (3/11 vs. 5/14, ), the small P = NS numbers of penicillin-resistant S. pneumoniae isolates lack sufficient power to enable us to make any specific conclusions regarding the relationship between exposure to antimicrobial agents and the prevalence of penicillin-resistant S. pneumoniae. All M. tuberculosis isolates were susceptible to isoniazid and rifampin; 1 isolate was streptomycin resistant and 1 was pyr-azinamide-resistant. All 8 S. typhimurium isolates were resistant to gentamicin and trimethoprim/sulfamethoxazole, the principal antimicrobials available for treating gram-negative infections in the study hospital.
Discussion
The BSI prevalence in adults presenting with fever to a large general hospital in Central Malawi was 30%; the HIV-1 seroprevalence and malaria parasitemia prevalences in this study cohort were 76% and 4%, respectively. The number of positive blood cultures increased as the number of clinical predictors present increased, ranging from 11% for patients with none of the independent clinical predictors of BSI to 100% in patients with all 3 independent risk factors. The percentage of patients with BSI in our study was higher than found in Nairobi (10%), Abidjan (17%), or Uganda (24%) [1, 2, 4] . Although differences in the prevalence of BSI may reflect differences in HIV-1 infection or in the stage of HIV-1 infection when patients present to the hospital, they also reflect the sensitivity of various blood culture methods used in these studies. Thus, the Tanzania BSI study [3] , which used blood culture methods similar to those used in our study and an identical patient case definition (fever) for enrollment, documented a BSI prevalence of 28% that was similar to our findings. In our study, S. pneumoniae was the most common pathogen responsible for BSI. This finding, though similar to that in the Kenya and Uganda studies [1, 4] , contrasts with the finding in Tanzania [3] , where culture techniques identical to ours were used, and with that in Cote d'Ivoire [2] . Although differences in prevalences of S. pneumoniae may reflect differences in culture technique, other possible explanations include geographic location (both Dar es Salaam and Abidjan are closer to seacoasts than are Nairobi or Lilongwe) and seasonal variation.
The prevalence of HIV-1 infection in our study population is high and reflects several factors and potential biases, including the selection criteria used to enroll patients, socioeconomic factors in the population served by the hospital, and the dynamics of the HIV-1 epidemic in various regions of sub-Saharan Africa. The percentage of patients infected with HIV-1 (76%) in our patients was similar to that in a 1998 study in Uganda [4] but higher than reported in Kenya (1989), Cô te d'Ivoire (1991), and Tanzania (1995) [1] [2] [3] . These differences in HIV-1 prevalence may relate to geographic location or year of the study.
The low prevalence of malaria parasitemia (4%) found in our cohort of febrile adults was not significantly different from that in a control group of healthy afebrile adults (7%). Given that 49% of the patients in our study were initially diagnosed with malaria and the common perception among the lay public and health care workers that malaria is a common cause of fever in these patients, we conclude that during the dry season, adults presenting to LCH with fever are frequently overdiagnosed with malaria. It is possible, however, that study patients with negative malaria smears were already receiving antimalarial prophylaxis or therapy that could be obtained from community clinics or bought over-the-counter before they attended LCH.
The data from our study support reports that in sub-Saharan Africa M. tuberculosis is a frequent cause of BSI [3, 4] and that M. avium complex is an uncommon cause of disseminated infection among HIV-1-infected persons [3, [8] [9] [10] [11] . We documented only 1 patient with M. avium complex BSI, the fifth reported case of disseminated M. avium complex infection in an HIV-1-infected patient in sub-Saharan Africa [3, 10] . The relative paucity of disseminated M. avium complex BSI is perplexing given the ubiquitous presence of M. avium complex in sub-Saharan Africa [11, 12] .
In many developing countries, limited clinical microbiology resources or the lack of trained personnel may preclude obtaining blood cultures where they are needed. Producing and maintaining a sufficient supply of quality-controlled laboratory reagents and media is a major challenge for providing accurate routine diagnostic microbiology services in underdeveloped settings. A more cost-effective approach to the use of limited microbiology resources than continuous clinician-directed laboratory testing as currently practiced in much of the developed world would be to base blood cultures or initial empiric therapy on clinical predictors. Data from our study indicate that HIV-1 infection is an independent risk factor for BSI in newly admitted febrile adults. Therefore, knowledge of HIV-1 status in these patients should facilitate the decision to initiate empiric antimicrobial therapy. However, we cannot make a blanket recommendation that HIV-1 testing be done routinely in areas of high HIV-1 seroprevalence in order to make a decision about initial empiric therapy, because many hospitals in Africa do not have the necessary financial or laboratory resources to test every patient suspected of having HIV-1 infection. Even in institutions where HIV-1 testing services are available (e.g., LCH), it could take up to 5 days before test results are available to clinicians. Thus, HIV-1 serology test results cannot realistically be used to make clinical decisions for newly hospitalized patients in HIV-1-endemic areas in less developed countries unless there is previous documentation. Notwithstanding, LCH physicians have a low threshold of suspicion for HIV-1 infection and generally are able to suspect underlying HIV-1 infection from a patient's history and physical examination.
Our data suggest that febrile patients with suspected or documented HIV-1 infection and clinical features, such as a history of chronic symptoms (fever, diarrhea, weight loss, or cough), altered mental status, herpes zoster scars, pulmonary physical signs, or oral candidiasis should be suspected of having BSI (bacteremia, mycobacteremia, or fungemia). The physician might wish to consider diagnostic tests, such as chest radiographs and/or sputum smear microscopy for bacteria and AFB, referral to the tuberculosis clinic, where appropriate, or initiation of empiric antibacterial therapy. Febrile patients with signs of pulmonary consolidation alone are at increased risk of having a bacteremia, probably caused by S. pneumoniae, and should be considered for bacterial blood cultures, if available, or treated with an appropriate empiric regimen. Because S. pneumoniae appears to be the most common bloodstream pathogen during the Malawi dry season, the spectrum of empiric therapy should be effective against this organism. The S. pneumoniae isolates from our study were largely resistant to trimethoprim/sulfamethoxazole and penicillin but susceptible to tetracycline, erythromycin, and chloramphenicol. Salmonellae were generally resistant to trimethoprim/sulfamethoxazole and gentamicin but were susceptible to chloramphenicol. Thus, chloramphenicol, depending on availability, should be considered for empiric therapy in patients suspected of having a BSI. Our data also suggest that during the dry season, newly admitted febrile adults with negative malaria blood smears are more likely to have a BSI; patients with altered mental status are more likely to have a BSI than cerebral malaria.
Our study had limitations. First, the etiology of BSI and clinical predictors of BSI may vary with the nature of the patient population (e.g., patients from areas of high HIV-1 endemicity), available diagnostic microbiology resources, geography of the country, and seasons. Thus, one cannot extrapolate the results of a 4-week study in Lilongwe, Malawi, to other regions in sub-Saharan Africa or to other countries. For clinical predictors to be useful, they must be determined for patient populations in regions where they would be used. Second, this study was conducted during the height of the Malawi dry season; prevalences of BSI and malaria may vary by season. Third, only 1 set of blood cultures (i.e., blood from 1 venepuncture) was obtained from each patient. Two sets of blood cultures might have yielded a larger number of organisms [13] . However, in countries with limited hospital and laboratory resources, only 1 set of blood cultures, drawn carefully and properly to minimize contamination rates, may be necessary. Fourth, high rates of malnutrition and HIV-1 infection (both of which may suppress the febrile response) occur in adults in Lilongwe, Malawi. Thus, it is possible that our study cohort could have excluded a significant number of afebrile, HIV-1-infected persons with BSI. And fifth, the type of antimicrobials used by study patients before presentation to LCH and the duration of such therapy were uncertain.
Studies such as this contribute to the global surveillance of emerging infectious diseases and antimicrobial resistance. M. simiae [14, 15] and possibly mycobacteria of the SAV group [16] represent emerging infections in HIV-1-infected patients of the developed world. The recent finding of these agents in the bloodstream of patients in Bangkok [5] and now in Lilongwe, Malawi, suggest their widespread emergence in the developing world. Our findings of decreased susceptibility to penicillin among S. pneumoniae and of trimethoprim/sulfamethoxazole and gentamicin resistance among salmonellae isolated from the bloodstream suggest that emerging antimicrobial resistance may be an increasing problem in sub-Saharan Africa. Through "probe" studies like this, the diversity of infecting pathogens and their clinical predictors can be determined; these data can be used to better target limited antimicrobials and improve patient outcomes in settings with limited resources.
